Rezolute’s Ersodetug Remains Under FDA Review as Congenital HI Data Build a Broader Picture

Rezolute (NASDAQ: RZLT) provided an important update this week on ersodetug, its investigational antibody for hyperinsulinism: the FDA is continuing to review additional data from the Phase 3 sunRIZE study as it evaluates a potential regulatory path forward in congenital hyperinsulinism. Hyperinsulinism is a condition in which excessive insulin activity drives blood glucose to dangerously…

Investor reviewing market data on a tablet with stock charts in the background, representing active trading in crypto mining and cybersecurity stocks.

PRISM Mid-Day Movers: Crypto Mining and Cybersecurity are Today’s Leaders.

Canaan Inc. (NASDAQ: CAN) shares were up 13.74% Friday, gaining $0.0424 to trade at $0.3511. The bitcoin-mining hardware company opened at $0.32 and climbed as high as $0.3579 during the session, extending a sharp intraday rebound from Thursday’s $0.3087 close. authID Inc. (NASDAQ: AUID) shares climbed 10.31% Friday to $0.3958, a gain of $0.037 from…

Wealthfront Crosses $100 Billion in Platform Assets While Rate Cuts Erode the Business That Built It

Wealthfront Corporation (NASDAQ: WLTH), a tech-driven financial platform serving digital-native savers and investors, reported fiscal second quarter 2027 results on September 9, 2026 for the quarter ended July 31, 2026. Total platform assets reached $99.0 billion, up 12% year over year, and CEO David Fortunato confirmed the company surpassed $100 billion in August. Revenue of…

Doctor holding a heart model and prescription bottle, illustrating cardiovascular drug development and Cardiol Therapeutics’ CardiolRx program.

Cardiol Therapeutics Files US$150 Million Shelf Prospectus Ahead of CardiolRx Milestones

Key Points Cardiol Therapeutics filed a preliminary US$150 million base shelf prospectus in Canada and a related Form F-10 registration statement with the U.S. Securities and Exchange Commission. If finalized, the shelf could allow Cardiol to issue securities over 25 months, including common shares, debt, warrants, subscription receipts, units, or a combination of securities. The…

Draganfly Wins a Five-Year Canadian Armed Forces Contract, Capping Three Defense Announcements in Four Days

Draganfly Inc. (NASDAQ: DPRO), a developer of drone solutions and systems, announced on September 11, 2026 that the Government of Canada awarded it a five-year contract to supply Low-Cost Tactical Intelligence, Surveillance and Reconnaissance uncrewed aircraft systems to the Canadian Armed Forces. The initial contract commits Canada to 100 systems, along with ground control stations,…

Gold number-one trophy with laurel leaves and confetti, representing Tenable’s top global market-share ranking in device vulnerability management.

Tenable Retains No. 1 Market Share in Device Vulnerability Management for Eighth Year

Key Points Tenable Holdings ranked first in worldwide device vulnerability and exposure management market share for the eighth consecutive year, according to IDC. IDC reported that Tenable held 24.6% of the global market and led its closest competitor by nearly $260 million. Tenable cited continued investment in AI-driven exposure management, application security, and security-control validation…

Oracle cloud infrastructure revenue jumped 121% to $7.4B in fiscal Q1, beating estimates. ORCL added 850MW of capacity and closed its $20B equity program.

Oracle’s AI Data Center Bet Delivers: Cloud Infrastructure Revenue Surges 121%

Oracle Corporation (NYSE: ORCL) delivered a fiscal first-quarter beat that landed squarely on the metric Wall Street cares about most. The company’s cloud infrastructure business more than doubled year over year, signaling that its aggressive artificial intelligence data center build-out has begun converting capital expenditure into revenue. Key Points Cloud infrastructure revenue jumped 121% to…

Patient undergoes transcranial magnetic stimulation treatment using a medical device, representing robotic TMS technology for psychiatric care.

NRx’s HOPE Therapeutics Prepares First Robotic TMS Deployment in Florida

Key Points NRx Pharmaceuticals’ HOPE Therapeutics subsidiary is preparing to deploy Zeta Surgical’s FDA-cleared robotic transcranial magnetic stimulation, or TMS, system in Florida clinics. HOPE said it will become the first interventional psychiatry network to use the Zeta TMS Robotic System. The system uses AI-guided software to track patient movement and adjust the TMS coil…

Archer and BETA Bring ACES Charging to Texas, Turning a Consortium Announcement Into a State Partnership

Archer Aviation Inc. (NYSE: ACHR), an aerospace company developing electric vertical takeoff and landing aircraft, announced on September 10, 2026 that America’s Consortium for Electric Skyways will bring its interoperable charging network to Texas. ACES, which Archer launched with BETA Technologies and Macquarie Capital, will support Texas Department of Transportation air taxi operations under the…

Person using a smartphone inside a cannabis cultivation facility, representing technology, digital platforms, and a potential shift in business strategy.

Cannabis Strategic Ventures Targets Mobile Ad-Tech Pivot With Proposed Adport Acquisition

Key Points Cannabis Strategic Ventures signed a non-binding letter of intent to acquire Adport’s operating assets and intellectual property. Adport develops mobile, battery-powered digital advertising screens for delivery riders and fleet operators. The company is running a New York pilot with nine screens used by nine delivery riders. If completed, the stock-for-assets deal would give…